Two major tech mergers are pending right now, with Intel planning to acquire Altera and Avago snapping up Broadcom. Many companies that make major acquisitions end up destroying value for shareholders (and this very issue is a debate in the Intel – Altera deal), but in the case of Intel and Avago, a study indicates that it's quite the opposite.
Intel, Avago outperform peers in M&A
Michelle Jones was a television news producer for eight years. She produced the morning news programs for the NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spent a short time at the CBS affiliate in Huntsville. She has experience as a writer and public relations expert for a wide variety of businesses.
The Iliad And The IPO: Corporate Legacy Andrew A. Schwartz University of Colorado Law School July 20, 2015 Harvard Business Law Review, Vol. 5, No. 2, pp. 237-80, 2015 U of Colorado Law... Read More
Morning Market Update Stocks that are expected to trade actively in U.S. markets on Monday include: Apple Inc. (NASDAQ:AAPL), Google Inc (NASDAQ:GOOG), McDonald's Corporation (NYSE:MCD), Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B),... Read More
Andreas Halvorsen opened up a new short in KONE Corporation (HEL:KNEBV), a Finnish escalator maker. Kone Corp is one of the largest cap companies in Finland, with $21 billion... Read More
There is enough blood on the street, a recent Macquarie Research piece says, and after the theater stocks have retreated 12 percent, it’s now time to buy beleaguered offerings. Why... Read More
Hedge funds are looking to bulk up their algorithmic divisions to an extent never before seen. A recent Bloomberg Brief article notes demand for quants is outstripping supply, as... Read More
Zynga Inc (NASDAQ:ZNGA), a company with a fate inextricably linked with that of Facebook Inc (NASDAQ:FB), has seen its stock price crumble since its highs last Spring. The company,... Read More
ValueWalk's Raul Panganiban interviews Nelson Wu, the founder of OpenSquare Capital. In this part, Nelson discusses what led him to investing, insider trading at Allergan, Actavis's acquisition of Allergan,... Read More
Stephen J. Errico of Locust Wood Capital Advisors, up 10% year to date, sees value in a forthcoming spin-off that Glenview Capital’s Larry Robbins also noticed. The New York-based... Read More
Jim Grant has difficulty “making heads or tails” of Mario Draghi, his choice of arcane inflation measures or his panic that inflation is too low. In the recent Grant's Observer,... Read More
J.C. Penney Company, Inc. (NYSE:JCP)’s failure to provide detailed information about holiday sales has already convinced most people that the retailer has lost its November momentum, raising serious questions... Read More
